BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
|Target Hit|| Long (1Y)
HDFC Securities Upgrades Dr Reddy's To 'Neutral'
With Dr Reddy26nbsp; Laboratories having received an EIR (Establishment Inspection Report) for its Bachupally (plant 3) formulations facility, this leaves the company with only the crucial Duvvada facility under significant regulatory action, says HDFC Securities.